For the second consecutive year, Ergon is supporting financially the Kick Cancer Fund, a fund dedicated to research in paediatric oncology managed by the King Baudouin Foundation.
Kick Cancer Fund finances clinical trials on innovative drugs with the view to improve our understanding of the origin and functioning of paediatric cancers, which will allow, in the long run, the development of new drugs for paediatric cancers.
Our manifesto: contributing to the development of sustainable finance
To succeed with this strategy, Apheon believes a holistic and collective approach is fundamental.
Holistic: it is essential that all aspects of ESG are equally and continuously supported. This is why we are active at every stage of the investment cycle by applying proprietarily developed methodologies and initiatives which are built on 5 priorities covering the broad ESG spectrum: